This study investigated the changes in the surface area and height of the papilla of Vater (PV) and the visibility of the sphincter of Oddi complex (SOK) using endoscopic ultrasound (EUS) examinations of 80 patients with symptomatic gallstones before and at 3 and 6 months after cholecystectomy. Following surgery, 50 patients experienced early atypical symptoms characteristic of postcholecystectomy syndrome (PCS) and 30 patients were asymptomatic. The PV measurements were greater in all patients compared with normal reference values and increased significantly from before surgery to 3 months postsurgery. At 6 months postsurgery, both the surface area and height of the PV had significantly decreased to preoperative values but remained higher than normal. The proportion of patients with a visible SOK had increased by 3 months postsurgery but had reduced again by 6 months. There were no significant differences between symptomatic and asymptomatic patients, suggesting that the changes observed in the PV and SOK do not explain the presence of the atypical symptoms of PCS.
Introduction
Overall, gallstone diseases represent a serious burden for healthcare systems. Each year > 190 000 cholecystectomies are performed in Germany and > 40 000 in Chile. 1, 2 Since the introduction of cholecystectomy as the main therapy in alleviating the symptoms of gallstones, adverse effects have emerged that are collectively described as 'postcholecystectomy syndrome' (PCS). 3 This syndrome represents a broad umbrella of atypical symptoms, such as nausea, bloating, distension and abdominal pain, that occur after the removal of the gallbladder. 3 The prevalence of these symptoms ranges from 20% to 50%. 4 When Some of the data included in this paper are from the PhD thesis by Marjan Skalicky entitled 'Research of changes in the papilla of Vater and the diameter of common bile duct in cholecystectomized patients' undertaken at the General Hospital Maribor (now the University Medical Centre Maribor), Slovenia and the University of Zagreb, Croatia, 1999 [in Croatian].
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investigating the causes of these symptoms, emphasis should not only be put on surgical intervention (i.e. cholecystectomy) used, but also on the morphological and functional changes in the papilla of Vater (PV) and its structures, and any changes to the common bile duct.
The region of the ampulla of the PV is a complex anatomical and functional entity, which is a biliopancreatic-duodenal confluence. There is a weak point in the duodenal wall at this site, commonly the site of mucosal diverticula. 5 Functional changes in the PV are, however, not completely understood and often do not correlate with clinical symptoms. Sphincter of Oddi dysfunction (SOD) is a clinical syndrome for which several terms have been used, including biliary dyskinesia, PCS and papillary stenosis, in response to lack of consensus about the precise aetiology of this abnormality. 6 The aetiology of this somatization disorder is unclear, but SOD patients may experience excessive smooth muscle contractility in the biliary tree and elsewhere. 7 Patients with fibromyalgia and SOD type III share many demographic and psychosocial characteristics with patients with irritable bowel syndrome. 8 SOD patients also exhibit increased psychological distress. 9 To enhance understanding of these changes, numerous examinations have been performed in the sphincter of Oddi complex (SOK), which represents an important functional and morphological part of the PV. SOD is a syndrome that is characterized by chronic biliary pain or recurrent pancreatitis due to functional obstruction of the pancreaticobiliary flow at the level of the sphincter of Oddi. 10 The Milwaukee classification system 11 stratifies patients according to their clinical picture based on elevated liver enzymes, a dilated common bile duct and the presence of abdominal pain. Type I SOD patients have pain as well as  abnormal liver enzymes and a dilated  common bile duct; type II SOD patients have  pain and only one objective finding; and type  III SOD patients only have biliary pain. 12 This classification system is useful for guiding diagnosis and management of SOD. The current 'gold standard' for diagnosis of SOD is manometry to detect elevated sphincter pressure, which correlates with the outcome of sphincterotomy. Manometry is not, however, widely available and is an invasive procedure that is associated with a risk of pancreatitis. Non-invasive testing methods, including fatty meal ultrasonography and scintigraphy, have shown limited correlation with manometric findings but may be useful in predicting outcome to sphincterotomy. 13 Endoscopic injection of botulinum toxin appears to predict the subsequent outcome of sphincterotomy and could be a useful therapy in a selection of patients, especially in the setting where manometry is not available. 14, 15 Research has indicated a strong probability that processes in the PV affect its size, height and surface area, and also the function of the SOK. 16 -18 SOD was found to be perceived by 1% of patients after cholecystectomy, but 14% of patients developed the atypical symptoms of PCS after the operation. 19 -22 The use of endoscopic retrograde cholangiography, manometry and peroral cholangioscopy examinations fail to explain the occurrence of SOD or atypical PCS symptoms. 23 -27 The use of percutaneous ultrasound examination for diagnosing changes in the PV area is very limited, so the use of endoscopic ultrasound (EUS), which provides better specificity and sensitivity in observing these structures, is highly recommended. 28 EUS is a semi-sensitive method of imaging with a low incidence of complications (0.2% of patients). 29 When they do occur,
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Impact of cholecystectomy on the papilla of Vater: anatomy complications tend to be milder; they include hypertonia, hypotonia, tachycardia, bradycardia and low oxygen saturation. Mortality in the first 30 days after the procedure has been reported in 0.003% of cases. 30 EUS uses lateral optics, which can cause complications when the endoscope is passed deep into the duodenum where innervations of the nervus vagus are more dense and expressive; this has to be taken into consideration when performing EUS. 31 -33 Use of EUS facilitates the organography of the PV, which enables analysis of anatomical structures. Furthermore, a high correlation between EUS and histography (i.e. the analysis of anatomical structures of size 0.2 -1 mm) and histology has been confirmed. 34 The aim of the present study was to monitor changes in the surface area and height of the PV in comparison with visibility of the SOK during EUS examination before and after cholecystectomy. The hypothesis was that changes that arise in the PV and SOK can be visualized and monitored by EUS examination in those patients who develop atypical symptoms after cholecystectomy. 35 -39 A companion paper in the same issue of this journal presents the PV echogenicity data for the same group of cholecystectomized patients. 40 
Patients and methods

PATIENTS
This study included uncomplicated patients with cholecystolithiasis, with no evidence of choledocholithiasis or cholestasis, who underwent cholecystectomy at the Department of Internal Medicine, General Hospital Maribor, Maribor, Slovenia, or at the Division of Internal Medicine Clinical Centre 'Sestre Milosrdnice', Zagreb, Croatia, between January 1996 and September 1998. The patients were enrolled sequentially into the study. A proportion experienced early atypical symptoms such as bloating, distension, nausea, and pain in the upper abdomen, while the remaining patients had no symptoms in the same period after cholecystectomy. A control group of patients examined for other diseases and in whom no abnormal changes in the PV were found was used for comparison. All patients were from the region of Maribor (Slovenia) and Zagreb (Croatia).
The study protocol was approved by the National Medical Ethics Committee of the Republic of Slovenia, Ljubljana, Slovenia. All patients participating in the study provided verbal informed consent.
EUS EXAMINATIONS
For EUS examination a GF-UM20 ultrasound gastroscope (Olympus Optical Co., Shibuyaku, Japan) was used with a 7.5 MHz probe and 360° rotation. When observing the PV, the probe was placed in a perpendicular and axial position in the descending duodenum. The height (hPV) and width (wPV) of the hemispherical PV were measured and the surface area of the PV (SPV) was calculated using the equation: 41 SPV = hPV × wPV/2 It is known that the PV is prism-shaped, so a correction factor (F kor ) was calculated on the basis of an isosceles triangular prism using the equation: F kor = P 1 /P 2 + P 3 = 1.27 where P 1 represents the surface area of the virtual isosceles triangle at the bottom of the PV, and P 2 and P 3 represent the surface area of the isosceles triangle on each side of the stylized hemispheric papilla. The SPV used in the statistical analysis was calculated using this correction factor, as follows: 41 Corrected SPV = SPV/ F kor = SPV/1.27
All patients underwent EUS to measure the SPV, hPV and the visibility of the SOK. The results were compared with normal
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values for the parameters of the PV. Normal reference values were calculated on the basis of measurements made in the control group and comparison of these measured values with those from other studies.
The visibility of the SOK was measured promptly after measurement of PV and was characterized qualitatively on the extent of the grey scale (ranging from white to black) observed on the EUS monitor as: (i) visible (PV and sphincter of Oddi were heteroechogenic), (ii) fairly visible (PV and sphincter of Oddi were anisoechogenic), and (iii) not visible (PV and sphincter of Oddi were isoechogenic). Structures that were anisoechogenic or 'fairly visible' depended on the amount/presence of hyper-and hypoechogenic (black-white) ultrasound scattering. 
STATISTICAL ANALYSES
Results
The study included 80 cholecystectomized patients; of these, 50 experienced early atypical symptoms, such as bloating, distension, nausea and pain in the upper abdomen at 3 and 6 months after cholecystectomy, and 30 patients had no symptoms in the same period. An typical EUS of an enlarged hypoechogenic PV from a patient with atypical symptoms following cholecystectomy is shown in Fig. 1 The measured values for the control group were compared with those reported in other studies and it was concluded that the normal SPV is 20 -25 mm 2 , with a mean ± SD width of 5.1 ± 2.1 mm and height 7.2 ± 1.6 mm; the SOK was not visible in the control group. 41, 42 Since differences in the hPV, SPV and the visibility of SOK between men and women were not statistically significant, the results were analysed for the samples as a whole. No signs of choledocholithiasis were found in the main bile duct and the PV in any of the participants. Tables 1 and 2 show the calculated SPV for the 50 symptomatic and asymptomatic patients, respectively, before and at 3 and 6 months after cholecystectomy. The SPV of symptomatic patients was significantly increased compared with control subjects at each time-point (P < 0.05). The SPV across all three different time-points in symptomatic patients also showed statistically significant differences (P < 0.005); it increased at 3 months after surgery (P < 0.05 versus prior to surgery) and had decreased by 6 months after surgery (P < 0.001 for 6 months versus 3 months after surgery). The SPV was still larger at 6 months than in controls (P < 0.05), although there was no statistically significant difference in SPV at 6 months compared with before surgery. Similar changes over time were observed in the asymptomatic patients (Table 2) and there was no significant difference between the two groups of cholecystectomized patients. Table 3 shows the hPV at the three timepoints in symptomatic and asymptomatic patients combined. As the SPV partially depends on the hPV and the sphincter of Oddi can be located within the hPV and, since there was no statistically significant difference in SPV between the symptomatic and asymptomatic patients, it was presumed 
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Impact of cholecystectomy on the papilla of Vater: anatomy that there would be no significant differences for hPV between the two groups and data for both groups were, therefore, combined. The hPV was significantly increased compared with controls at each time-point (P < 0.05). The hPV also showed statistically significant differences across all three different timepoints (P < 0.005); it increased at 3 months after surgery versus before surgery (P < 0.005) and significantly decreased from 3 to 6 months after surgery (P < 0.001). There was no statistically significant difference in the hPV before surgery compared with 6 months after surgery. It was concluded that hPV and SPV followed the same pattern of changes visible by EUS. Prior to cholecystectomy 9.9 ± 3.4 9.0 (6.0 -21.0) χ 2 = 10.92 3 months after cholecystectomy 10.8 ± 3.6 10.0 (6.0 -24.0) P < 0.005 6 months after cholecystectomy 9.4 ± 2.3 8.5 (6.0 -16.0) a As the surface area of the papilla of Vater (SPV) partially depends on the hPV and the sphincter of Oddi is located within the papilla of Vater and, since there was no statistically significant difference in the surface area of the papilla of Vater between symptomatic and asymptomatic patients, it was presumed that there would be no significant differences for hPV between the two groups and data for both groups were, therefore, combined. b Measured values in 24 patients examined for other diseases and in whom no abnormal changes in the PV were found were compared with the literature 41, 42 and it was concluded that the normal mean ± SD hPV (control) was 7.2 ± 1.6 mm. c All measurements of hPV were statistically significant versus the normal value, P < 0.05 (Friedman's analysis of variance); prior to versus 3 months after cholecystectomy, Z = 3.05 (Wilcoxon signed-rank test); P < 0.005 (Friedman's analysis of variance); prior to versus 6 months after cholecystectomy, Z = 1.26 (Wilcoxon signedrank test); not statistically significant (P > 0.05; Friedman's analysis of variance); 3 months versus 6 months after cholecystectomy, Z = 3.67 (Wilcoxon signed-rank test); P < 0.001 (Friedman's analysis of variance). Table 4 shows the visibility of the SOK in symptomatic and asymptomatic patients before and at 3 and 6 months after cholecystectomy. The SOK was visible or fairly visible before cholecystectomy in 52% of symptomatic patients and in 72% of symptomatic patients at 3 months after cholecystectomy (P < 0.05 versus prior to surgery). The proportion of symptomatic patients in whom the SOK was not visible decreased significantly from 48% before cholecystectomy to 28% at 3 months after cholecystectomy (P < 0.05). There was no significant difference in the visibility of the SOK between symptomatic and asymptomatic patients. Table 5 shows that a significant change in visibility of the SOK occurred at 3 months after surgery compared with before surgery (P < 0.05). Before surgery, the SOK was visible or fairly visible in 26 cases and at 3 months after surgery it was visible/fairly visible in 36 cases. It was not visible in 24 cases before surgery and only in 14 cases at 3 months after surgery. Visibility of the SOK was significantly increased by 3 months after surgery (P < 0.05). The difference in the visibility of the SOK at 6 months after surgery was not statistically significant compared with before surgery, but the difference at 3 versus 6 months after surgery was highly significant (P < 0.001). As there were no significant differences between symptomatic and asymptomatic groups, Table 5 shows data only for the 50 symptomatic patients. Table 6 summarizes the statistical analysis of the changes in the SPV, hPV and visibility of the SOK before and after cholecystectomy. It is clear that the SPV and the hPV followed a similar pattern of changes as that of the visibility of the SOK.
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Discussion
Changes in hPV can suggest the existence of various physiological conditions. For example, the size and shape of the PV can change due to inflammation, oedema, glandular hyperplasia or adenomyomatosis. 42, 43 The range of normal values for the PV was established for the present study by performing measurements in healthy (43) 16 (53) 30 (100) Percentages may not total 100% due to rounding. a Visibility was determined qualitatively based on the extent of the grey scale (ranging from white to black) observed on the endoscopic ultrasound monitor: (i) visible (papilla of Vater and sphincter of Oddi were heteroechogenic), (ii) fairly visible (papilla of Vater and sphincter of Oddi were anisoechogenic), and (iii) not visible (papilla of Vater and sphincter of Oddi were isoechogenic). b Prior to versus 3 months after cholecystectomy P < 0.05 (Stuart χ 2 test). Prior to versus 3 months after cholecystectomy P < 0.05 P < 0.005 P < 0.05 Prior to versus 6 months after cholecystectomy NS NS NS 3 months versus 6 months after cholecystectomy P < 0.001 P < 0.001 
Comparison
P < 0
1046
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individuals and comparing them with data from published studies. 41, 42 Compared with the SPV in healthy subjects, 41, 44 it was significantly increased to more than twice the size in patients with symptomatic gallstones. These findings suggest that the presence of gallstones has an important effect on the size of the PV and that the SPV, as measured by EUS, increases as a consequence. The SPV also increased as a result of the cholecystectomy procedure. To our knowledge there is little similar research on this in the published literature. 41 The present study clearly demonstrated that the hPV and SPV, as well as the visibility of the SOK, 
changed during the process of gallstone development and after cholecystectomy. The natural history of the changes to the PV prior to surgery remain unknown, but it can be presumed that the postsurgical enlargement of the PV, as well as the significant increase in the visibility of the SOK, are a consequence of the surgical procedure.
At 6 months after surgery, the measurements showed a decrease in both the hPV and SPV, with values slightly less than preoperative values yet higher than normal values, suggesting that the changes were, at least in part, irreversible in both symptomatic and asymptomatic patients. Thus, the PV reacts to the surgical procedure in a transient way, with it returning to a preoperative state by 6 months after surgery. Factors, such as surgery and other stressful events, induce additional enlargement of the PV and increase the visibility of the SOK, which is important to consider when evaluating PCS.
Statistical analysis of the changes in the hPV, the SPV and the visibility of the SOK from the preoperative time-point to 3 months after cholecystectomy produced a similar pattern of statistical significance, suggesting that the changes in the PV were manifest as an increased visibility of the SOK as a consequence of modified scattering during EUS.
Histomorphologically, the SOK lies in the muscular layer of the muscularis mucosa and embryonically it belongs to the choledochoampullary segment of the PV, which has an influence on the SPV and the hPV as it controls changes in the mucosal part of the PV. 45 Dancygier 46 established that, embryonically, the submucosal part of the PV belongs to the ampulloduodenal segment. This is why the dynamic changes in this area are subject to inexplainable behaviour patterns when observing cholecystectomized patients; i.e on ultrasound, significant differences occur in the biliary or duodenal component of the PV, as demonstrated in the present study and in the companion paper published in the same issue of this journal. 40 Considering that, statistically, the same significant changes were observed in both the papillary choledochoampullary segments (hPV and SOK) and in symptomatic and asymptomatic cholecystectomized patients, the PCS explanation of the type III Milwaukee classification remains open and speculative. Moreover, the use of acupuncture in energetic functioning of various organs like the PV and SOK is still relatively unknown. Acupuncture has been used empirically to treat various disorders in gastroenterology, but it is only during the last two decades that scientific studies have been conducted. In general, acupuncture is thought to have dual-direction effects on gastrointestinal motility and secretion; when motility or secretion are decreased or increased, acupuncture at a special acupoint (or acupoints) appears to restore these functions to normal levels. 47 Over the last two decades, increasing numbers of reports of physiological and clinical studies of acupuncture have appeared in Chinese language publications that document and validate its use for gastrointestinal disorders. 47 Acupuncture alone or as an adjuvant can produce analgesia in 50 -80% of patients with pain caused by a variety of disorders including gastrointestinal and biliary colicky pain. 48 Acupuncture also has been used for biliary diseases such as cholelithiasis and PCS. 49 Electroacupuncture stimulation of acupoint GB 34 results in reversible inhibition of SOK contraction in humans. 50 50 The development of PCS as a consequence of passing microcrystals/ microliths is not an issue in SOD. 51 Since there is no available simple mechanistic explanation for early and late PCS, it would be reasonable to apply the knowledge of interactive/integrative medicine to the treatment of this condition. 52, 53 The technique of EUS is uniquely appropriate for examination of the PV, particularly because it detects small macrohistological changes induced by ultrasound scattering. The echogenicity of the PV, which is under ampulloduodenal 'command', can be affected by the same proactive neurohumoural mechanisms as in functional dyspepsia of the upper alimentary canal. 54, 55 In the course of this, mucosal structures of the ampullocholedochal segment of the PV are actively included, which objectively control the size of the PV and its tissue echogenicity. 41,56 -58 It might, therefore, be useful for future research on the PV and the SOK to analyse the influence of the phytopharmaceutical STW 5 (Iberogast ® ; Steigerwald Arzneimittelwerk, Darmstadt, Germany) on functional dyspepsia. Additional neurohumoural irritants might also help in forming a clearer clinical picture of PCS. 16 In conclusion, patients with the following clinical picture are suitable for further treatment: (i) where the size of the PV is irreversibly doubled; and (ii) where the SOK is visible. Treatment with phytopharmaceuticals and other additional elements of integrative medicine are suitable if the clinical symptoms of PCS are present. Since the SOK is not visible in a normal PV, it would be reasonable also to treat patients with a visible SOK and an associated clinical picture of PCS. Endoscopic injection of the botulinum toxin into the PV is a safe procedure and provides short-term relief of symptoms in half of patients with type III SOD. 59 Published studies also indicate that the clinical response to botulinum toxin injection can predict whether SOD patients will gain long-term benefit from endoscopic sphincterotomy. 59 -61 It would make sense to perform an EUS-guided injection into the visible SOK. Targeted positioning of the botulinum toxin in the specific area of the SOK could improve the results, but this potential therapeutic method has not yet been reported in the literature.
